Cargando…
Synergistic Anti-Cancer Effect of Phenformin and Oxamate
Phenformin (phenethylbiguanide; an anti-diabetic agent) plus oxamate [lactate dehydrogenase (LDH) inhibitor] was tested as a potential anti-cancer therapeutic combination. In in vitro studies, phenformin was more potent than metformin, another biguanide, recently recognized to have anti-cancer effec...
Autores principales: | Miskimins, W. Keith, Ahn, Hyun Joo, Kim, Ji Yeon, Ryu, Sun, Jung, Yuh-Seog, Choi, Joon Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897486/ https://www.ncbi.nlm.nih.gov/pubmed/24465604 http://dx.doi.org/10.1371/journal.pone.0085576 |
Ejemplares similares
-
Crystal structure of oxamyl
por: Kwon, Eunjin, et al.
Publicado: (2016) -
Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer
por: Park, Ji‐Hye, et al.
Publicado: (2019) -
Oxamate Attenuates Glycolysis and ER Stress in Silicotic Mice
por: Mao, Na, et al.
Publicado: (2022) -
Ammonium N-(pyridin-2-ylmethyl)oxamate (AmPicOxam): A Novel Precursor of Calcium Oxalate Coating for Carbonate Stone Substrates
por: Pintus, Anna, et al.
Publicado: (2023) -
Phenformin as an Anticancer Agent: Challenges and Prospects
por: García Rubiño, Mª Eugenia, et al.
Publicado: (2019)